Philips Healthcare (NYSE:PHG) and Infraredx expanded the scope of their alliance with a resale deal that will see the Dutch healthcare giant sell Infraredx’s TVC imaging platform alongside Philips’ Allura X-ray device.
The deal calls for Philips to sell the TVC device, which uses near-infrared spectroscopy and intravascular ultrasound to provide images of coronary blood vessels, in North America and Europe, according to a press release.
The companies have been cooperating since October 2012, when they announced plans to integrate the Infraredx and Allura technologies. In March Philips and Infraredx released the fruit of that venture, an integrated cardiology suite.
"Our goal is to further improve existing image-guided interventions and therapies and to enable new ones," Philips Healthcare interventional X-ray general manager Ronald Tabaksblat said in prepared remarks. "By teaming up with Infraredx to sell the TVC imaging system, our product portfolio will be enhanced with an innovative intravascular imaging technology that works seamlessly with our interventional X-ray systems for better-informed treatment decisions and real-time therapy monitoring."
"We’re pleased to partner with Philips, the leader in interventional X-ray systems, to expand access to our innovative TVC imaging system among Philips’ broad and established customer base in North America and Europe," added Infraredx president & CEO Don Southard. "This resale agreement advances our global commercialization strategy by increasing our product’s penetration in the cardiac imaging market."
DeviceTalks West is just a few days away. Join more than 300 of your peers for a day of world-class education, networking, and a technology exhibition featuring the leading companies in the industry.
Don’t miss out on this premier opportunity to come together and share perspectives with the best of the best in the industry.
Use code LASTCHANCE to save an additional 20%.